Kriya Medical Technologies bags manufacturing license for RT-PCR Kit
14 February 2022 | News
The KRIVIDA Novus RT-PCR kit can detect the Omicron variant, its sub-lineages, and the Delta variant in 45 minutes
Kriya Medical Technologies has received its manufacturing license from the DCGI (Drugs Controller General of India) for its product KRIVIDA Novus, an RT-PCR kit that can detect the Omicron variant and its sub-lineages in 45 minutes.
Priced at Rs 150 +taxes, the test is affordable and most suitable for entry point screening at airports. The kit is compatible with Real-Time PCR machines with a test run time of roughly 45 minutes. It provides an early report to aid diagnosis and also gives precise variants to enable appropriate treatment.
KRIVIDA Novus will be produced at Kriya’s state-of-the-art manufacturing facility in Oragadam in Chennai. The company currently has a production capacity of 5 million tests per month and plans to increase it to 10 million tests per month within the next two weeks.
